Suri Harris, CAHG
Advertisement
Suri Harris is EVP, Strategic Planning/New Ventures, at CAHG.
Articles by Suri Harris, CAHG
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
What Kinds of Disruption are GLP-1s Expected to Face
2
FDA Approves Datroway for Patients with Metastatic Triple-Negative Breast Cancer Who Are Not PD-1/PD-L1 Inhibitor Candidates
3
Director of NIH Infectious Disease Institute Steps Down
4
Eli Lilly and Novo Nordisk Shift Patients From Compounded Drugs to Lower-Cost Weight-Loss Pills: Report
5